Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration
Ophthalmology Retina · 2025
DOI: 10.1016/j.oret.2024.08.014 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von Junran Sun und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research…. Hauptthemen laut MEDLINE: Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Visual Acuity, Wet Macular Degeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Ophthalmic Diseases, Shanghai, China; Shanghai Key Laborat…
- Department of Ophthalmology, General Hospital of Central Theater Command, Wuhan, China.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Ophthalmic Diseases, Shanghai, China.
- Department of Ophthalmology, The Second Hospital of Anhui Medical University, Hefei, China.
- Department of Ophthalmology, Jinan Second People's Hospital, Jinan, China.
- The Eye Hospital Affiliated to Shandong Traditional Chinese Medicine University, Jinan, China.
Zitieren
APA
Sun, J., Song, Y., Gong, Y., Tao, L., Wang, H., Shu, X., Wen, Y., Cui, L., Ye, J., Lu, S., Deng, J., Li, H., Xu, Y., Qian, L., Wu, Z., Bi, Y., Liu, Q., Xu, X., Wu, M., …, & Sun, X. (2025). Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.08.014
Vancouver
Sun J, Song Y, Gong Y, Tao L, Wang H, Shu X, et al. Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2024.08.014
BibTeX
@article{Sun2025,
author = {Sun, Junran and Song, Yanping and Gong, Yuanyuan and Tao, Liming and Wang, Hong and Shu, Xiangwen and Wen, Ying and Cui, Ling and Ye, Jian and Lu, Shujie and Deng, Junjie and Li, Haoyu and Xu, Yihua and Qian, Lei and Wu, Zhifeng and Bi, Yanlong and Liu, Qinghuai and Xu, Xiangzhong and Wu, Miaoqin and Zhang, Jinglin and Hao, Jilong and Tong, Jianping and Dai, Hong and Wang, Feng and Zhao, MingWei and Mao, Junfeng and Li, Chaopeng and He, Tao and Pei, Cheng and Liu, Xiaoling and Wang, Xian and Li, Mingxin and Wang, Wei and Zheng, Qinxiang and Guan, Huaijin and Peng, Hui and Fan, Ke and Zhang, Wenfang and Zhu, Dan and Yu, Songping and Wei, Wenbin and Ding, Lin and Li, Jinying and Lu, Peirong and Yan, Ming and Liu, Wei and Jia, Huixun and Sun, Xiaodong},
title = {Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration},
journal = {Ophthalmology Retina},
year = {2025},
doi = {10.1016/j.oret.2024.08.014}
}
EUVIMED